Nagy J A, Henriksson P, McDonagh J
Blood. 1986 Dec;68(6):1272-9.
The plasma transglutaminase, factor XIIIa (FXIIIa), circulates as a zymogen containing two proteins, A and B, arranged in a noncovalent tetrameric complex, A2B2. Biosynthesis of plasma FXIII has not previously been demonstrated. In the present study, direct evidence has been obtained that two human hepatoma cell lines, Hep G2 and PLC/PRF/5, synthesize and secrete FXIII B protein. Secretion of the B subunit of FXIII by Hep G2 was demonstrated by immunoblotting. De novo synthesis by Hep G2 was confirmed in 35S-methionine-labeled cultures. Radiolabeled conditioned medium was concentrated, mixed (1:1) with purified B protein, and examined by crossed immunoelectrophoresis with antiserum to the B subunit. The single protein precipitin arc of purified B protein comigrated with the radiolabeled FXIII from Hep G2 visualized by autoradiography, indicating both electrophoretic and antigenic identity. The data presented here represent the first demonstrations of biosynthesis of FXIII B protein by any cell type and suggest that the liver is the site of synthesis of FXIII B protein. Further analysis of concentrated Hep G2 serum-free conditioned medium (SFCM) and cell lysate by immunoblotting following nondenaturing agarose gel electrophoresis demonstrated the FXIII A protein as well as the B protein and also revealed synthesis and secretion of the A and B proteins by PLC/PRF/5. Crossed immunoelectrophoresis studies of Hep G2 SFCM and cell lysate suggest that Hep G2 cells also synthesize and secrete the plasma FXIII zymogen. With a specific radioimmunoassay for B protein, FXIII was found in Hep G2 SFCM at approximately 4 ng/mL; with an amplified rocket immunoelectrophoresis technique the level was approximately 5 ng/mL.
血浆转谷氨酰胺酶,即因子ⅩⅢa(FXIIIa),以一种酶原形式循环,它包含两种蛋白质A和B,以非共价四聚体复合物A2B2的形式排列。此前尚未证实血浆FXIII的生物合成。在本研究中,已获得直接证据表明,两种人肝癌细胞系,即Hep G2和PLC/PRF/5,能够合成并分泌FXIII B蛋白。通过免疫印迹法证实了Hep G2分泌FXIII的B亚基。在35S-甲硫氨酸标记的培养物中证实了Hep G2的从头合成。将放射性标记的条件培养基浓缩,与纯化的B蛋白按1:1混合,并用抗B亚基抗血清进行交叉免疫电泳检测。纯化B蛋白的单一蛋白质沉淀弧与通过放射自显影观察到的来自Hep G2的放射性标记FXIII迁移一致,表明两者在电泳和抗原性上相同。此处呈现的数据首次证明了任何细胞类型均可生物合成FXIII B蛋白,并提示肝脏是FXIII B蛋白的合成部位。通过非变性琼脂糖凝胶电泳后免疫印迹法对浓缩的Hep G2无血清条件培养基(SFCM)和细胞裂解物进行进一步分析,证实了FXIII A蛋白以及B蛋白的存在,同时也揭示了PLC/PRF/5合成并分泌A蛋白和B蛋白。对Hep G2 SFCM和细胞裂解物进行的交叉免疫电泳研究表明,Hep G2细胞也能合成并分泌血浆FXIII酶原。通过针对B蛋白的特异性放射免疫测定法,在Hep G2 SFCM中检测到FXIII的含量约为4 ng/mL;采用放大火箭免疫电泳技术,该水平约为5 ng/mL。